Trump’s Tariff Shock: Big Blow for Indian Exports
On Sept 25, 2025, Donald Trump announced sweeping tariffs across pharma, consumer goods, and industrials, escalating trade tensions.
🔹 Key Tariffs
Pharma: 100% duty on branded/patented drugs (from Oct 1). Only firms investing in U.S. manufacturing exempt.
Consumer Goods: 50% tariff on cabinets & vanities, 30% on upholstered furniture, 25% on heavy trucks.
Future Scope: Probes underway on robotics, machinery, and medical devices for possible new duties.
🔹 Impact on India
Tariff Burden: 50% effective duty on Indian exports (25% base + 25% penalty for Russian oil purchases) — highest in decades.
Exports Hit: India’s shipments to U.S. down 22.2% (May–Aug 2025), from $8.8B to $6.9B.
Sectors Under Pressure: Textiles, gems & jewelry, pharma, chemicals, marine products, furniture.
🔹 Consequences
Pharma majors may need U.S. facilities to avoid 100% duty.
Export-heavy states like Gujarat face job risks.
PLI-led investments slowing; competitiveness weakening.
Trade talks stalled after 5 failed negotiation rounds.
Bottomline: India faces one of the toughest trade environments in years, with U.S. tariffs reshaping supply chains and squeezing exporters.
📌 Stocks to Watch
Pharma: